Ophthalmic artery occlusion following local hyaluronic acid injection: A case report.

Medicine (Baltimore)Sep 11, 2026
Case ReportOphthalmologyOpen access

Ziqi Xiong, Haiming Lv, Chunhuan Niu et al.

✦ AI-curated · Sources linked

Case in brief

A 46-year-old female experienced sudden vision loss and skin mottling after hyaluronic acid injection into the nasal bridge. Initial treatment included intravenous dexamethasone and thrombolysis, but no visual improvement occurred. Upon further evaluation, she was diagnosed with ophthalmic artery occlusion. Despite integrated treatment combining traditional Chinese and Western medicine, her visual acuity remained no light perception, with progressive retinal atrophy noted over 10 months.

Diagnostic / clinical pearl

Clinicians should be aware that ophthalmic artery occlusion can occur following hyaluronic acid injections, leading to severe visual impairment, and should maintain a high index of suspicion for this rare complication.

Why it matters

This case highlights the need for standardized injection techniques and risk prevention measures in aesthetic procedures to enhance patient safety and minimize the risk of serious complications.

Source

Published in Medicine (Baltimore). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.